Navigation Links
House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels
Date:12/20/2007

Bill assures patients continue to have access to ZEVALIN(R) and other novel

radioimmunotherapies

SEATTLE, Dec. 20 /PRNewswire-FirstCall/ -- New Medicare legislation passed by the House and Senate extends the 2007 reimbursement methodology for radiopharmaceuticals into 2008. The Centers for Medicare and Medicaid Services (CMS) had implemented new hospital outpatient reimbursement rates for 2008 for radiopharmaceuticals like ZEVALIN(R) (Ibritumomab Tiuxetan) below their acquisition costs. The drugs are used to fight relapsed non-Hodgkin's lymphoma, which for some patients can provide additional therapeutic options. The new Medicare legislation will maintain the current methodology for reimbursement of therapeutic radiopharmaceuticals for the first six months of 2008, giving the drugs' manufacturers and CMS time to seek a permanent reimbursement procedure that more accurately reflects hospital costs associated with the therapy.

"We applaud law makers for responding to the concerns of patients and providers regarding these important therapeutic options for treating patients with this deadly disease," said CTI President and CEO James A. Bianco, M.D. "This legislation will maintain the status quo and provide the drug manufacturers the opportunity to work with CMS on developing an equitable methodology for reimbursing therapeutic radiopharmaceuticals."

Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) has signed an agreement to acquire the U.S. marketing, sales and development rights to ZEVALIN from Biogen Idec, Inc., which it expects to close later this month. Until the transaction is closed, ZEVALIN remains a product and trademark of Biogen Idec, Inc.

About ZEVALIN(R)

ZEVALIN(R) (Ib
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
2. The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio
3. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
4. MyClyns(TM), a New Standard of Personal Protection, is Announced at the EMS and Firehouse Central EXPO
5. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
8. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
9. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... DIEGO , Aug. 3, 2015  Halozyme Therapeutics, ... Update Conference Call for the second quarter 2015 on ... PT. Dr. Helen Torley , president and chief ... date post-market, Halozyme will release financial results for the ... webcast live through the "Investors" section of Halozyme,s corporate ...
(Date:8/3/2015)... ... 03, 2015 , ... The synthetic rubber industry is recognized ... as ethylbenzene, a precursor to styrene, used to make styrene-butadiene resins, styrene butadiene ... production of tyres and other components. Thus, growth in the automotive industry is ...
(Date:8/3/2015)... 3, 2015 E-QURE Corp. (OTCQB: ... its Bio-electrical Signal Therapy device ("BST Device"), a new ... to heal chronic wounds, today announced that the Company ... Israeli distributor specializing in medical devices, for the marketing ... is a 70 years old, sales, marketing and distribution ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech Corporation introduces the compact, ... of analytical laboratory equipment. With optimized features, such as PTFE-coated contact surfaces, an ... and maintenance-free solution for a broad range of vacuum filtration applications. , Featuring ...
Breaking Biology Technology:Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3Sterlitech Launches New Line of Vacuum Pumps 2
... March 13 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; OTC: MGIFF), ... results for the three and nine months ended,January 31, ... DeMesa, M.D., President & CEO of MIGENIX stated, "With ... halfway through our,fourth quarter, we are looking forward to ...
... ARNA ) announced today that the company is scheduled to,provide ... programs, at two upcoming investor conferences:, -- Cowen ... Wednesday, March 19, 2008 at 8:45 a.m. Eastern Time (5:45 ... Marriott Copley Place in Boston, Massachusetts ...
... REINACH, Switzerland, March 13 Arpida Ltd,(SWX: ARPN) announced ... 2007., 2007 highlights, Major pipeline progress:, ... in cSSSI,achieves its pre-specified primary endpoint, as did the ... for intravenous iclaprim in,cSSSI initiated, - First patients ...
Cached Biology Technology:MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 2MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 3MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 4MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 5MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 6MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 7MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 8MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 9MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 10MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 11MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 12MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 13MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 14MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 15MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results 16Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences 3Arpida Announces Full Year 2007 Financial Results 2Arpida Announces Full Year 2007 Financial Results 3Arpida Announces Full Year 2007 Financial Results 4Arpida Announces Full Year 2007 Financial Results 5Arpida Announces Full Year 2007 Financial Results 6Arpida Announces Full Year 2007 Financial Results 7Arpida Announces Full Year 2007 Financial Results 8Arpida Announces Full Year 2007 Financial Results 9
(Date:7/23/2015)... Inc. (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended June 30, 2015.  Revenue for ... of 33% compared to $6.8 million in the same quarter ... was $0.3 million, or $0.01 per diluted share, which compared ... same period a year ago.  Lower revenue ...
(Date:7/20/2015)... -- Acuity Market Intelligence,s latest research "The Global Biometrics ... Privacy" forecasts that between 2014 and 2020 nearly ... to smart mobile devices by 2.2 billion mobile ... to generate more than $67.9 billion in total ...    "Biometrics is at the center ...
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... Miami (UM) students have received prestigious Graduate Research Fellowships ... work on coral reefs. Rachel Silverstein and Nitzan Soffer ... work in the laboratory of Dr. Andrew Baker, an ... Fisheries at UMs Rosenstiel School of Marine and Atmospheric ...
... OSU researchers received grants totaling more than $240,000 last ... Science and Technology under its Oklahoma Applied Research Support ... potential for producing a commercially successful product, according to ... Oklahoma businesses, universities and non-profit organizations to accelerate the ...
... Rochelle, NY -- As the Nobel Foundation recognizes the ... DNA, the newly formed Rosalind Franklin Society celebrates the ... made this breakthrough possible. Although Franklin was ... late Francis Crick, the late Maurice Wilkins, and James ...
Cached Biology News:Everything's coming up corals 2Everything's coming up corals 3OCAST funds OSU projects with commercial viability 2
... Product Goat polyclonal to Cholesterol ... Reactivity / Specificity Cross-reacts with ... Background Information Cholesterol oxidases exist ... oxidases and are implicated in bacterial pathogenesis. ...
Phospho-PERK (Thr980) Antibody...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
Sheep polyclonal to Staphylococcus DNase ( Abpromise for all tested applications). Antigen: Full length native protein (purified)....
Biology Products: